Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)

SHA:688488 Revenue

Jiangsu Aidea Pharmaceutical Group had revenue of 178.02M CNY in the quarter ending March 31, 2026, a decrease of -10.03%. This brings the company's revenue in the last twelve months to 699.33M, up 33.77% year-over-year. In the year 2025, Jiangsu Aidea Pharmaceutical Group had annual revenue of 719.17M with 72.13% growth.

• Revenue (ttm): 699.33M
• Revenue Growth: +33.77%
• P/S Ratio: 10.36
• Revenue / Employee: 951.47K
• Employees: 735
• Market Cap: 7.24B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	719.17M	301.37M	72.13%
Dec 31, 2024	417.80M	6.44M	1.57%
Dec 31, 2023	411.36M	167.14M	68.44%
Dec 31, 2022	244.22M	-11.49M	-4.49%
Dec 31, 2021	255.71M	-33.35M	-11.54%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 11, 2026

Data Sources Report a data error